ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy, safety, and tolerability of single
doses of trospium inhalation powder (TrIP) administered to subjects with chronic obstructive
pulmonary disease (COPD).